Trial intelligence / Profile preview

Atorvastatin in Stable Moderate to Severe Asthma

NCT00292201Phase 2Terminated

Sponsor
Queen's University
Start
Feb 2006
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atorvastatin in asthma, sponsored by Queen's University. Started Feb 2006; status: terminated.

02

Drugs

atorvastatin
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00292201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00292201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call